WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATC 5th levels

List of latest ATC/DDD decisions from the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the decisions should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline (see list). If no objections are received, the new ATC/DDD decisions will be considered final and included in the ATC/DDD Index. In the list final indicates that the date for objection has expired. The year of implementation in the ATC/DDD Index is given in the list.

Please note that the ATC and DDD alterations are only valid and implemented in the coming annual updates of January 1st.

ATC codeATC level nameDeadline for objection to temporary codesImplementation in ATC/DDD index
V09IA10technetium (99mTc) trofolastat chloride01.09.20232024
V04CX11lithium chloride01.09.20232024
S01HA08chloroprocaine01.09.20232024
R03AK15salbutamol and budesonide01.09.20232024
N07XX23troriluzole01.09.20232024
N07XX22tofersen01.09.20232024
N06DX05donanemab01.09.20232024
N06AX62bupropion and dextromethorphan01.09.20232024
M09AX15delandistrogene moxeparvovec01.09.20232024
L04AJ09danicopan01.09.20232024
L04AJ08iptacopan01.09.20232024
L04AJ07crovalimab01.09.20232024
L04AG16rozanolixizumab01.09.20232024
L04AE05etrasimod01.09.20232024
L03AA19eflapegrastim01.09.20232024
L01XX80imetelstat01.09.20232024
L01XX79eflornithine01.09.20232024
L01XX78navitoclax01.09.20232024
L01XL11lifileucel01.09.20232024
L01XL10nadofaragene firadenovec01.09.20232024
L01FY03prolgolimab and nurulimab01.09.20232024
L01FX29talquetamab 01.09.20232024
L01FX28glofitamab01.09.20232024
L01FX27epcoritamab01.09.20232024
L01FX26mirvetuximab soravtansine01.09.20232024
L01FF13toripalimab01.09.20232024
L01EX27capivasertib01.09.20232024
L01EX26sitravatinib01.09.20232024
J07BX06enterovirus 71 vaccines01.09.20232024
J05AR28stavudine and lamivudine01.09.20232024
J05AP13ravidasvir01.09.20232024
J05AE11ensitrelvir01.09.20232024
J01DD58cefixime and beta-lactamase inhibitor01.09.20232024
H05BX06evocalcet01.09.20232024
H05AA05palopegteriparatide01.09.20232024
H02AB18vamorolone01.09.20232024
D11AH12nemolizumab01.09.20232024
D11AH11delgocitinib01.09.20232024
D11AH10lebrikizumab01.09.20232024
D03AX16beremagene geperpavec01.09.20232024
C10BX21rosuvastatin and perindopril01.09.20232024
C10AB12pemafibrate01.09.20232024
C09BX07zofenopril and nebivolol01.09.20232024
C04AX33clazosentan01.09.20232024
C02KN01aprocitentan01.09.20232024
B05XA20sodium selenite01.09.20232024
B05XA19calcium gluconate01.09.20232024
B02BD16etranacogene dezaparvovec01.09.20232024
B01AD13apadamtase alfa and cinaxadamtase alfa01.09.20232024
B01AC28limaprost01.09.20232024
A10XX01teplizumab01.09.20232024
A10BK08bexagliflozin01.09.20232024
A05AX06elafibranor01.09.20232024
A01AB53chlorhexidine and cetylpyridinium01.09.20232024
V03AB54pralidoxime and atropineFinal2024
S01XA31pegcetacoplanFinal2024
S01CA12loteprednol and antiinfectivesFinal2024
S01BA16difluprednateFinal2024
S01AX24polihexanideFinal2024
S01AA32bacitracinFinal2024
P02BA03arpraziquantelFinal2024
N07XX21eplontersenFinal2024
N07XX19sodium phenylbutyrate and ursodoxicoltaurineFinal2024
N06DX04lecanemabFinal2024
N05CJ03daridorexantFinal2024
N02CC51sumatriptan and naproxenFinal2024
N02BA67magnesium salicylate, combinations excl. psycholepticsFinal2024
N02AJ23hydrocodone and ibuprofenFinal2024
N02AJ22hydrocodone and paracetamolFinal2024
N02AD51pentazocine and naloxoneFinal2024
M09AX14givinostatFinal2024
M04AC51colchicine and probenecidFinal2024
M01AE57naproxen and diphenhydramineFinal2024
L04AJ06zilucoplanFinal2024
L04AG15divozilimabFinal2024
L04AF08ritlecitinibFinal2024
L04AC25levilimabFinal2024
L04AC24mirikizumabFinal2024
L03AX22leniolisibFinal2024
L03AB17sampeginterferon beta-1aFinal2024
L02BX53abiraterone and prednisoloneFinal2024
L02BA04elacestrantFinal2024
L01XL09tabelecleucelFinal2024
L01XL08lisocabtagene maraleucelFinal2024
L01XK52niraparib and abirateroneFinal2024
L01FX25mosunetuzumabFinal2024
L01FX24teclistamabFinal2024
L01FF12serplulimabFinal2024
L01FF11sugemalimabFinal2024
L01EL05pirtobrutinibFinal2024
L01EL04orelabrutinibFinal2024
L01EK04fruquintinibFinal2024
L01EJ04momelotinibFinal2024
L01BC58decitabine, combinationsFinal2024
J07BX05respiratory syncytial virus vaccinesFinal2024
J07BN05covid-19, virus-like particlesFinal2024
J01DE51cefepime and beta-lactamase inhibitorFinal2024
J01DC52cefuroxime and beta-lactamase inhibitorFinal2024
G04BX17sodium salicylate and methenamineFinal2024
G04BD15vibegronFinal2024
D05AX07tapinarofFinal2024
D05AX06roflumilastFinal2024
C10BX20rosuvastatin and telmisartanFinal2024
C09BX06perindopril, bisoprolol, amlodipine and indapamideFinal2024
C05XX01beperminogene perplasmidFinal2024
C05AX06phenylephrineFinal2024
C01CX10omecamtiv mecarbilFinal2024
C01CA28centhaquineFinal2024
B06AX05exagamglogene autotemcelFinal2024
B02BX10concizumabFinal2024
B02BD15valoctocogene roxaparvovecFinal2024
B01AF51rivaroxaban and acetylsalicylic acidFinal2024
A16AX23leriglitazoneFinal2024
A16AB27pabinafusp alfaFinal2024
A16AB26eladocagene exuparvovecFinal2024
A10BD29sitagliptin and dapagliflozinFinal2024
A10BD28metformin and teneligliptinFinal2024
A10AE07insulin icodecFinal2024
A07FA03escherichia coliFinal2024
A05AA05ursodoxicoltaurineFinal2024
A02BX16irsogladineFinal2024
A02BD17vonoprazan and amoxicillinFinal2024
A02BC51omeprazole, combinationsFinal2024

Last updated: 2023-05-11